Axonics Inc.

AI Score

XX

Unlock

70.98
0.00 (0.00%)
At close: Nov 14, 2024, 9:00 PM
0.00%
Bid n/a
Market Cap 3.63B
Revenue (ttm) 432.08M
Net Income (ttm) -5.66M
EPS (ttm) -0.1
PE Ratio (ttm) -709.8
Forward PE 82.93
Analyst n/a
Ask n/a
Volume 0
Avg. Volume (20D) 458,235
Open undefined
Previous Close 70.98
Day's Range 70.98 - 70.98
52-Week Range 55.09 - 71.05
Beta 0.83

About AXNX

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacra...

Sector Healthcare
IPO Date Oct 31, 2018
Employees 797
Stock Exchange NASDAQ
Ticker Symbol AXNX
Full Company Profile